Shiga Toxin Producing Bacterial Infection

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Shiga Toxin Producing Bacterial Infection trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05219110

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

The objective of this study is to determine if early high volume intravenous fluid administration (hyperhydration) may be effective in mitigating or preventing…

United States1,040 participantsStarted 2022-09-29

Treatment: Infusion of 200% maintenance fluids as balanced crystalloid IV solution, Oral fluids; infusion of up to 110% maintenance fluids as balanced crystalloid IV solution

All recent trials (3 shown)

CompletedPhase 2

NCT01252199

Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2

This study is designed to evaluate the safety and efficacy of cαStx1 and cαStx2 administered concomitantly in children presenting early signs of Shiga Toxin-Pro…

Argentina45 participantsStarted 2010-11

Treatment: cαStx1/cαStx2, Placebo

CompletedNot Applicable

NCT01406288

Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4

The Hemolytic Uremic Syndrome (HUS) in its typical form occurs after a food born infection with a shiga-toxin secreting bacteria, usually Escherichia coli of th…

France9 participantsStarted 2011-07

Treatment: HUS standard coverage care (including in ICU)